Because the MTTP gene likely contributes to the development of hepatic steatosis, evaluating changes in MTTP gene expression may offer clues for the early monitoring of hepatic steatosis and HCC risk among HCV patients. The gene discussed is MT-TP; the disease is hepatocellular carcinoma.